Tuesday, July 15, 2014 6:58:24 PM
https://finance.search.yahoo.com/search/;_ylc=X3oDMTJtN2poNzRjBGtleXcDQ2FubmFiaW5vaWQgUmVjZXB0b3IgTW9kdWxhdG9ycwRtaWQDbWVkaWFxdW90ZXNzZWFyY2gEc2VjA3VoYjIEc2xrA2ZpbmFuY2Vfc2VhcmNo?p=Cannabinoid%20Receptor%20Modulators&type=2button&fr=uh3_finance_vert_gs
N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3 ...
en.wikipedia.org/wiki/N-(S)-Fenchyl-1-(2-morpholinoethyl... Cached
Further reading . 1. John Hynes., et al. C3 AMIDO-INDOLE CANNABINOID RECEPTOR MODULATORS. Bioorganic and Medical Chemistry Letters. Volume 12 issue 17, 2 September ...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM